Clinical Trial Update: Methotrexate for Central Serous Chorioretinopathy Treatment Trial [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating methotrexate for Central Serous Chorioretinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Edward Averbukh | Conditions: Central Serous Chorioretinopathy | Phase 2 | Status: UNKNOWN